Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP (1548)
My previous session
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
08/07/2018 08/08/2018 08/09/2018 08/10/2018 08/13/2018 Date
17.42 17.72 17.96 17.82 16.84 Last
11576800 8488600 6290531 5200300 9567000 Volume
+1.40% +1.72% +1.35% -0.78% -5.50% Change
Financials (HKD)
Sales 2018 1 549 M
EBIT 2018 359 M
Net income 2018 311 M
Finance 2018 196 M
Yield 2018 -
Sales 2019 1 858 M
EBIT 2019 384 M
Net income 2019 355 M
Debt 2019 173 M
Yield 2019 -
P/E ratio 2018 104,27
P/E ratio 2019 85,18
EV / Sales2018 19,8x
EV / Sales2019 16,7x
Capitalization 30 894 M
More Financials
Company
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services.It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products.The... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
08/05JOHNSON & JOHNSON : J&J Bets on Chinese Startup That Uses Llama DNA to Fight Can..
DJ
07/05GENSCRIPT BIOTECH : Bio to build manufacturing center in Zhenjiang
AQ
06/28GENSCRIPT BIOTECH : Bio in CAR-T immuno-cell therapy team-up
AQ
06/22GENSCRIPT BIOTECH : Bio unit inks clinical cooperation deal
AQ
06/05GENSCRIPT BIOTECH : Bio to raise HK$2.37bn from placing
AQ
05/31GENSCRIPT BIOTECH : Legend Announces FDA Clearance of IND Application on CAR-T I..
AQ
05/31GENSCRIPT BIOTECH : Bio's new drug approved for clinical trial by US
AQ
03/19GENSCRIPT BIOTECH : Bio year net down 0.2% to US$26.12m; no div
AQ
01/12GENSCRIPT BIOTECH : Bio completes US oligo pools business buy
AQ
01/04GENSCRIPT BIOTECH : Acquires CustomArray to Expand Synthetic Biology Product Por..
AQ
More news
Sector news : Bio Diagnostics & Testing
08/03Roche Drug for Brain Disease Granted European Fast-Track
DJ
08/02Regeneron Closes Up 7% After 2Q Earnings Beat -- Data Talk
DJ
08/02REGENERON PHARMACEUTICALS : Beats Earnings Estimates
DJ
07/31UNITED THERAPEUTICS : Medtronic Get FDA OK for Remodulin Implantable System
DJ
07/27JOHNSON & JOHNSON : J&J's Janssen Gets Positive CHMP Opinion for Darzalex as Fro..
DJ
More sector news : Bio Diagnostics & Testing
Latest Tweets
2017BRIEF-Genscript Biotech Says US, Ireland Units ?& Janssen Biotech Enter C.. 
2017Genscript Biotech soars 20 per cent after cancer drug wins go-ahead for clini.. 
More tweets
Qtime:3
News from SeekingAlpha
05/02China's Democracy Vs The U.S. Tweetocracy 
03/09Danaher Agrees To Acquire Integrated DNA Technologies For Genetic Tech 
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 43,2  HKD
Spread / Average Target 156%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP-17.65%3 936
MIRACA HOLDINGS INC.-42.64%1 444
IOVANCE BIOTHERAPEUTICS INC87.50%1 246
BEIJING STRONG BIOTECHNOLOGIES INC--.--%873
INVITAE CORP--.--%666
SEEGENE INC--.--%601